epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Coxanto

oxaprozin

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Cardiovascular Thrombotic Event

NSAIDs incr. risk of serious and potentially fatal cardiovascular thrombotic events, including MI and stroke; risk may occur early in tx and may incr. with duration of use; contraindicated in CABG periop setting

GI Bleeding, Ulceration, and Perforation

NSAIDs incr. risk of serious and potentially fatal GI adverse events including bleeding, ulcer, and stomach or intestine perforation; GI events may occur at any time during use and without warning symptoms; elderly patients and patients with history of PUD or GI bleeding at greater risk for serious GI events

Adult Dosing .

Dosage forms:  CAP: 300 mg

osteoarthritis

[1200 mg PO qd]
Max: 1200 mg/day; Info: start 600 mg PO qd if low body wt; use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs

rheumatoid arthritis

[1200 mg PO qd]
Max: 1200 mg/day; Info: start 600 mg PO qd if low body wt; use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs

for anti-inflammatory uses (off-label)

[1200 mg PO qd]
Max: 1200 mg/day; Info: start 600 mg PO qd if low body wt; use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs

pain, mild-moderate (off-label)

[1200 mg PO qd]
Max: 1200 mg/day; Info: start 600 mg PO qd if low body wt; use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs

renal dosing

[see below]
mild-moderate impairment: consider decr. usual dose; severe impairment: avoid use; Alt: start 600 mg qd, max 1200 mg qd; advanced renal disease: avoid use
HD: avoid use; Alt: start 600 mg qd, max 1200 mg qd; no supplement after dialysis; PD: avoid use; Alt: start 600 mg qd, max 1200 mg qd; no supplement

hepatic dosing

[see below]
mild-moderate impairment: no adjustment; severe impairment: not defined, caution advised

Peds Dosing .

Dosage forms:  CAP: 300 mg

juvenile idiopathic arthritis

[6-16 yo, 22-31 kg]
Dose: 600 mg PO qd; Max: 1200 mg/day; Info: use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs
[6-16 yo, 32-54 kg]
Dose: 900 mg PO qd; Max: 1200 mg/day; Info: use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs
[6-16 yo, >55 kg]
Dose: 1200 mg PO qd; Max: 1200 mg/day; Info: use lowest effective dose, shortest effective tx duration; may divide dose bid; give with food if GI upset occurs

renal dosing

[not defined]
renal impairment: consider adult renal dosing for guidance
HD/PD: consider adult renal dosing for guidance

hepatic dosing

[not defined]
hepatic impairment: consider adult hepatic dosing for guidance

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@1d2fa50
  • hypersensitivity to drug or ingredient
  • hypersensitivity to ASA
  • hypersensitivity to NSAIDs
  • asthma, ASA-induced
  • asthma, NSAID-induced
  • urticaria, ASA-induced
  • urticaria, NSAID-induced
  • aspirin triad
  • renal impairment, severe
  • renal disease, advanced
  • pregnancy starting at 30 wk gestation
  • CABG surgery periop use
  • CHF, severe
  • MI, recent
  • GI bleeding
  • GI bleeding history
  • PUD history
  • dehydration
  • hypovolemia
  • avoid: sun exposure
  • avoid: UV light exposure, artificial
  • caution: pregnancy at <30 wk gestation
  • caution: elderly patients
  • caution: debilitated patients
  • caution: renal impairment
  • caution: hepatic impairment
  • caution: asthma
  • caution: cardiovascular disease
  • caution: cardiac disease risk
  • caution: HTN
  • caution: CHF
  • caution: fluid retention
  • caution: coagulation disorder
  • caution: smokers
  • caution: alcohol use, concurrent
  • caution: prolonged use
  • caution: patients of childbearing potential trying to conceive

Drug Interactions .

Overview

oxaprozin

NSAID

Interaction Characteristics:
  • affects growth hormone diagnostic test results
  • alters gallbladder contraction/motility
  • antiplatelet effects
  • decreases renal perfusion/fxn
  • GI mucosal injury/bleeding risk
  • hyperkalemia
  • hypertensive effects
  • hyponatremia
  • lowers seizure threshold
  • photosensitivity
  • thrombogenic effects

Contraindicated

  • ketorolac
  • Coxanto (oxaprozin)
    +
    ketorolac
    1 interaction

    Contraindicated

    oxaprozin + ketorolac

    ketorolac injection, tablet: contraindicated; ketorolac nasal: avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

Avoid/Use Alternative

  • amikacin
  • Coxanto (oxaprozin)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amiloride
  • Coxanto (oxaprozin)
    +
    amiloride
    1 interaction

    Avoid/Use Alternative

    oxaprozin + amiloride

    if hypokalemia use, monitor potassium, renal fxn, potassium, BP; otherwise, avoid combo: combo may incr. risk of renal impairment, hyperkalemia; may decr. amiloride efficacy (additive effects; antagonistic effects)

  • aminolevulinic acid topical
  • Coxanto (oxaprozin)
    +
    aminolevulinic acid topical
    1 interaction

    Avoid/Use Alternative

    oxaprozin + aminolevulinic acid topical

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • aspirin
  • Coxanto (oxaprozin)
    +
    aspirin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + aspirin

    avoid aspirin >325 mg/day; otherwise, monitor renal fxn, bleeding s/sx: combo may incr. risk of renal impairment, GI ulceration, perforation, bleeding (including life-threatening), other adverse effects (additive effects, duplicate therapy)

  • bumetanide
  • Coxanto (oxaprozin)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    oxaprozin + bumetanide

    use alternative or monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. bumetanide efficacy (additive effects; antagonistic effects)

  • celecoxib
  • Coxanto (oxaprozin)
    +
    celecoxib
    1 interaction

    Avoid/Use Alternative

    oxaprozin + celecoxib

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • clofarabine
  • Coxanto (oxaprozin)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    oxaprozin + clofarabine

    avoid oxaprozin during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, hypotension, other adverse effects (additive effects)

  • diclofenac
  • Coxanto (oxaprozin)
    +
    diclofenac
    1 interaction

    Avoid/Use Alternative

    oxaprozin + diclofenac

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • diclofenac topical
  • Coxanto (oxaprozin)
    +
    diclofenac topical
    1 interaction

    Avoid/Use Alternative

    oxaprozin + diclofenac topical

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • diflunisal
  • Coxanto (oxaprozin)
    +
    diflunisal
    1 interaction

    Avoid/Use Alternative

    oxaprozin + diflunisal

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • enoxaparin
  • Coxanto (oxaprozin)
    +
    enoxaparin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + enoxaparin

    use alternative or monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • epinephrine inhaled
  • Coxanto (oxaprozin)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    oxaprozin + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • etodolac
  • Coxanto (oxaprozin)
    +
    etodolac
    1 interaction

    Avoid/Use Alternative

    oxaprozin + etodolac

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • fenoprofen
  • Coxanto (oxaprozin)
    +
    fenoprofen
    1 interaction

    Avoid/Use Alternative

    oxaprozin + fenoprofen

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • flurbiprofen
  • Coxanto (oxaprozin)
    +
    flurbiprofen
    1 interaction

    Avoid/Use Alternative

    oxaprozin + flurbiprofen

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • fondaparinux
  • Coxanto (oxaprozin)
    +
    fondaparinux
    1 interaction

    Avoid/Use Alternative

    oxaprozin + fondaparinux

    use alternative or monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • ibuprofen
  • Coxanto (oxaprozin)
    +
    ibuprofen
    1 interaction

    Avoid/Use Alternative

    oxaprozin + ibuprofen

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • ibuprofen lysine
  • Coxanto (oxaprozin)
    +
    ibuprofen lysine
    1 interaction

    Avoid/Use Alternative

    oxaprozin + ibuprofen lysine

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), renal impairment, other adverse effects (additive effects, duplicate therapy)

  • indomethacin
  • Coxanto (oxaprozin)
    +
    indomethacin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + indomethacin

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • ketoprofen
  • Coxanto (oxaprozin)
    +
    ketoprofen
    1 interaction

    Avoid/Use Alternative

    oxaprozin + ketoprofen

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • lisinopril
  • Coxanto (oxaprozin)
    +
    lisinopril
    1 interaction

    Avoid/Use Alternative

    oxaprozin + lisinopril

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • macimorelin
  • Coxanto (oxaprozin)
    +
    macimorelin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + macimorelin

    avoid combo or D/C oxaprozin, allowing sufficient washout time before diagnostic test: combo may interfere with test results (oxaprozin may affect pituitary secretion of growth hormone)

  • magnesium salicylate
  • Coxanto (oxaprozin)
    +
    magnesium salicylate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + magnesium salicylate

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), renal impairment, HTN (additive effects)

  • meclofenamate
  • Coxanto (oxaprozin)
    +
    meclofenamate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + meclofenamate

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • mefenamic acid
  • Coxanto (oxaprozin)
    +
    mefenamic acid
    1 interaction

    Avoid/Use Alternative

    oxaprozin + mefenamic acid

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • meloxicam
  • Coxanto (oxaprozin)
    +
    meloxicam
    1 interaction

    Avoid/Use Alternative

    oxaprozin + meloxicam

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • methotrexate
  • Coxanto (oxaprozin)
    +
    methotrexate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + methotrexate

    use alternative if high-dose methotrexate; otherwise, monitor CBC, renal fxn, bleeding s/sx: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, GI ulceration, perforation, bleeding (including life-threatening), other adverse effects (additive effects)

  • midodrine
  • Coxanto (oxaprozin)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    oxaprozin + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • nabumetone
  • Coxanto (oxaprozin)
    +
    nabumetone
    1 interaction

    Avoid/Use Alternative

    oxaprozin + nabumetone

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • naproxen
  • Coxanto (oxaprozin)
    +
    naproxen
    1 interaction

    Avoid/Use Alternative

    oxaprozin + naproxen

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • oxaprozin
  • Coxanto (oxaprozin)
    +
    oxaprozin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + oxaprozin

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • pemetrexed
  • Coxanto (oxaprozin)
    +
    pemetrexed
    1 interaction

    Avoid/Use Alternative

    oxaprozin + pemetrexed

    avoid combo at least 5 days before, during and x2 days after pemetrexed use; monitor CBC, renal fxn, especially if concomitant renal impairment: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • piroxicam
  • Coxanto (oxaprozin)
    +
    piroxicam
    1 interaction

    Avoid/Use Alternative

    oxaprozin + piroxicam

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • porfimer
  • Coxanto (oxaprozin)
    +
    porfimer
    1 interaction

    Avoid/Use Alternative

    oxaprozin + porfimer

    avoid combo: combo may incr. risk of photosensitivity reaction, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • potassium chloride
  • Coxanto (oxaprozin)
    +
    potassium chloride
    1 interaction

    Avoid/Use Alternative

    oxaprozin + potassium chloride

    IV potassium chloride: use alternative or monitor potassium, ECG; ORAL potassium: monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium phosphate
  • Coxanto (oxaprozin)
    +
    potassium phosphate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + potassium phosphate

    use alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • pralatrexate
  • Coxanto (oxaprozin)
    +
    pralatrexate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + pralatrexate

    use alternative or monitor CBC: combo may incr. pralatrexate levels, risk of myelosuppression, other adverse effects (renal excretion possibly decreased)

  • salsalate
  • Coxanto (oxaprozin)
    +
    salsalate
    1 interaction

    Avoid/Use Alternative

    oxaprozin + salsalate

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, renal impairment, other adverse effects (additive effects)

  • sulindac
  • Coxanto (oxaprozin)
    +
    sulindac
    1 interaction

    Avoid/Use Alternative

    oxaprozin + sulindac

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • tacrolimus
  • Coxanto (oxaprozin)
    +
    tacrolimus
    1 interaction

    Avoid/Use Alternative

    oxaprozin + tacrolimus

    consider alternative or monitor tacrolimus levels, renal fxn, BP, potassium: combo may incr. tacrolimus levels, risk of nephrotoxicity, HTN, hyperkalemia, other adverse effects (additive effects)

  • tenofovir disoproxil
  • Coxanto (oxaprozin)
    +
    tenofovir disoproxil
    1 interaction

    Avoid/Use Alternative

    oxaprozin + tenofovir disoproxil

    use alternative or monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tolmetin
  • Coxanto (oxaprozin)
    +
    tolmetin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + tolmetin

    avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

  • tranexamic acid
  • Coxanto (oxaprozin)
    +
    tranexamic acid
    1 interaction

    Avoid/Use Alternative

    oxaprozin + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

  • vaccinia immune globulin
  • Coxanto (oxaprozin)
    +
    vaccinia immune globulin
    1 interaction

    Avoid/Use Alternative

    oxaprozin + vaccinia immune globulin

    use alternative or monitor thrombosis s/sx, renal fxn; use lowest vaccinia immune globulin concentration and infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism, nephrotoxicity (additive effects)

  • valsartan
  • Coxanto (oxaprozin)
    +
    valsartan
    1 interaction

    Avoid/Use Alternative

    oxaprozin + valsartan

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • willow bark
  • Coxanto (oxaprozin)
    +
    willow bark
    1 interaction

    Avoid/Use Alternative

    oxaprozin + willow bark

    avoid combo: combo may incr. risk of renal impairment, GI ulceration, perforation, bleeding (including life-threatening), other adverse effects (additive effects, duplicate therapy, willow bark may contain salicylates)

Monitor/Modify Tx

  • abemaciclib
  • Coxanto (oxaprozin)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + abemaciclib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • abiraterone acetate
  • Coxanto (oxaprozin)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • abrocitinib
  • Coxanto (oxaprozin)
    +
    abrocitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + abrocitinib

    monitor platelets, bleeding or thrombosis s/sx; bleeding risk may be lower at abrocitinib doses <200 mg/day; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism, bleeding, including life-threatening (additive effects)

  • acalabrutinib
  • Coxanto (oxaprozin)
    +
    acalabrutinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + acalabrutinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • acebutolol
  • Coxanto (oxaprozin)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • acyclovir
  • Coxanto (oxaprozin)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + acyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Coxanto (oxaprozin)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + adefovir dipivoxil

    monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased, additive effects)

  • ado-trastuzumab emtansine
  • Coxanto (oxaprozin)
    +
    ado-trastuzumab emtansine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ado-trastuzumab emtansine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • afatinib
  • Coxanto (oxaprozin)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + afatinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • aflibercept
  • Coxanto (oxaprozin)
    +
    aflibercept
    1 interaction

    Monitor/Modify Tx

    oxaprozin + aflibercept

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • albuterol
  • Coxanto (oxaprozin)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + albuterol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • albuterol inhaled
  • Coxanto (oxaprozin)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + albuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aldesleukin
  • Coxanto (oxaprozin)
    +
    aldesleukin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + aldesleukin

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • alendronate
  • Coxanto (oxaprozin)
    +
    alendronate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + alendronate

    monitor bleeding s/sx: combo may incr. risk of upper GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • aliskiren
  • Coxanto (oxaprozin)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    oxaprozin + aliskiren

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • allopurinol
  • Coxanto (oxaprozin)
    +
    allopurinol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + allopurinol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • almotriptan
  • Coxanto (oxaprozin)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • alpha-tocopherol (vitamin E)
  • Coxanto (oxaprozin)
    +
    alpha-tocopherol (vitamin E)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + alpha-tocopherol (vitamin E)

    monitor bleeding signs/symptoms, especially with alpha-tocopherol doses >800 units/day: combo may increase risk of bleeding, including life-threatening (additive effects)

  • alprostadil intracavernous
  • Coxanto (oxaprozin)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    oxaprozin + alprostadil intracavernous

    monitor injection site bleeding signs/symptoms: combo may increase risk of localized bleeding (additive effects)

  • alprostadil intravenous
  • Coxanto (oxaprozin)
    +
    alprostadil intravenous
    1 interaction

    Monitor/Modify Tx

    oxaprozin + alprostadil intravenous

    monitor bleeding signs/symptoms: combo may increase risk of bleeding, including life-threatening (additive effects)

  • alteplase
  • Coxanto (oxaprozin)
    +
    alteplase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + alteplase

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • amikacin inhaled
  • Coxanto (oxaprozin)
    +
    amikacin inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + amikacin inhaled

    monitor renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • aminocaproic acid
  • Coxanto (oxaprozin)
    +
    aminocaproic acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + aminocaproic acid

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • amlodipine
  • Coxanto (oxaprozin)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Coxanto (oxaprozin)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amphotericin
  • Coxanto (oxaprozin)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + amphotericin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • anacaulase topical
  • Coxanto (oxaprozin)
    +
    anacaulase topical
    1 interaction

    Monitor/Modify Tx

    oxaprozin + anacaulase topical

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • anagrelide
  • Coxanto (oxaprozin)
    +
    anagrelide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + anagrelide

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • angiotensin II
  • Coxanto (oxaprozin)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    oxaprozin + angiotensin II

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • anthrax immune globulin
  • Coxanto (oxaprozin)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + anthrax immune globulin

    monitor renal fxn, thrombosis s/sx; use lowest anthrax immune globulin infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • anti-inhibitor coagulant complex
  • Coxanto (oxaprozin)
    +
    anti-inhibitor coagulant complex
    1 interaction

    Monitor/Modify Tx

    oxaprozin + anti-inhibitor coagulant complex

    monitor thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • Coxanto (oxaprozin)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    1 interaction

    Monitor/Modify Tx

    oxaprozin + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • antithrombin
  • Coxanto (oxaprozin)
    +
    antithrombin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + antithrombin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • apixaban
  • Coxanto (oxaprozin)
    +
    apixaban
    1 interaction

    Monitor/Modify Tx

    oxaprozin + apixaban

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • aprocitentan
  • Coxanto (oxaprozin)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Coxanto (oxaprozin)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + arformoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • argatroban
  • Coxanto (oxaprozin)
    +
    argatroban
    1 interaction

    Monitor/Modify Tx

    oxaprozin + argatroban

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • armodafinil
  • Coxanto (oxaprozin)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • Coxanto (oxaprozin)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + asciminib

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • asparaginase
  • Coxanto (oxaprozin)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + asparaginase

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism (additive effects)

  • atenolol
  • Coxanto (oxaprozin)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atidarsagene autotemcel
  • Coxanto (oxaprozin)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + atidarsagene autotemcel

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • atogepant
  • Coxanto (oxaprozin)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    oxaprozin + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atomoxetine
  • Coxanto (oxaprozin)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Coxanto (oxaprozin)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • auranofin
  • Coxanto (oxaprozin)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + auranofin

    monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avapritinib
  • Coxanto (oxaprozin)
    +
    avapritinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + avapritinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • avatrombopag
  • Coxanto (oxaprozin)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    oxaprozin + avatrombopag

    monitor platelets, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • axitinib
  • Coxanto (oxaprozin)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + axitinib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • azilsartan medoxomil
  • Coxanto (oxaprozin)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + azilsartan medoxomil

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • balsalazide
  • Coxanto (oxaprozin)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + balsalazide

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • baricitinib
  • Coxanto (oxaprozin)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + baricitinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • bazedoxifene
  • Coxanto (oxaprozin)
    +
    bazedoxifene
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bazedoxifene

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • benazepril
  • Coxanto (oxaprozin)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + benazepril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • benzphetamine
  • Coxanto (oxaprozin)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betamethasone
  • Coxanto (oxaprozin)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + betamethasone

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), sodium/water retention, edema (additive effects)

  • betaxolol
  • Coxanto (oxaprozin)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Coxanto (oxaprozin)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bevacizumab

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • binimetinib
  • Coxanto (oxaprozin)
    +
    binimetinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + binimetinib

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism (additive effects)

  • bismuth subsalicylate
  • Coxanto (oxaprozin)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bismuth subsalicylate

    monitor bleeding signs/symptoms, BP with high-dose bismuth subsalicylate: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • bisoprolol
  • Coxanto (oxaprozin)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bivalirudin
  • Coxanto (oxaprozin)
    +
    bivalirudin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bivalirudin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • botulism immune globulin
  • Coxanto (oxaprozin)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + botulism immune globulin

    monitor renal fxn, thrombosis s/sx; use lowest botulism immune globulin concentration and infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • brentuximab vedotin
  • Coxanto (oxaprozin)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + brentuximab vedotin

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • brigatinib
  • Coxanto (oxaprozin)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • brolucizumab
  • Coxanto (oxaprozin)
    +
    brolucizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + brolucizumab

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • bromelain
  • Coxanto (oxaprozin)
    +
    bromelain
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bromelain

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • bromfenac ophthalmic
  • Coxanto (oxaprozin)
    +
    bromfenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bromfenac ophthalmic

    monitor bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • budesonide
  • Coxanto (oxaprozin)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bupropion
  • Coxanto (oxaprozin)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    oxaprozin + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • C1 esterase inhibitor
  • Coxanto (oxaprozin)
    +
    C1 esterase inhibitor
    1 interaction

    Monitor/Modify Tx

    oxaprozin + C1 esterase inhibitor

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • cabazitaxel
  • Coxanto (oxaprozin)
    +
    cabazitaxel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cabazitaxel

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • cabozantinib
  • Coxanto (oxaprozin)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cabozantinib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • caffeine
  • Coxanto (oxaprozin)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Coxanto (oxaprozin)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • calaspargase
  • Coxanto (oxaprozin)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + calaspargase

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism (additive effects)

  • candesartan cilexetil
  • Coxanto (oxaprozin)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + candesartan cilexetil

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cangrelor
  • Coxanto (oxaprozin)
    +
    cangrelor
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cangrelor

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • cannabis
  • Coxanto (oxaprozin)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • capecitabine
  • Coxanto (oxaprozin)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + capecitabine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • caplacizumab
  • Coxanto (oxaprozin)
    +
    caplacizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + caplacizumab

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • captopril
  • Coxanto (oxaprozin)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + captopril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • carboplatin
  • Coxanto (oxaprozin)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + carboplatin

    monitor CBC, renal fxn, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Coxanto (oxaprozin)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + carfilzomib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • carvedilol
  • Coxanto (oxaprozin)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorothiazide
  • Coxanto (oxaprozin)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + chlorothiazide

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorothiazide efficacy (additive effects; antagonistic effects)

  • chlorthalidone
  • Coxanto (oxaprozin)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + chlorthalidone

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • chorionic gonadotropin
  • Coxanto (oxaprozin)
    +
    chorionic gonadotropin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + chorionic gonadotropin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • cidofovir
  • Coxanto (oxaprozin)
    +
    cidofovir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cidofovir

    monitor CBC, renal fxn: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • cilostazol
  • Coxanto (oxaprozin)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cilostazol

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • cinacalcet
  • Coxanto (oxaprozin)
    +
    cinacalcet
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cinacalcet

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • cisplatin
  • Coxanto (oxaprozin)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cisplatin

    monitor CBC, renal fxn, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • citalopram
  • Coxanto (oxaprozin)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    oxaprozin + citalopram

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • clevidipine
  • Coxanto (oxaprozin)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clindamycin
  • Coxanto (oxaprozin)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + clindamycin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clonidine
  • Coxanto (oxaprozin)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clopidogrel
  • Coxanto (oxaprozin)
    +
    clopidogrel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + clopidogrel

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • clozapine
  • Coxanto (oxaprozin)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + clozapine

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor IX
  • Coxanto (oxaprozin)
    +
    coagulation factor IX
    1 interaction

    Monitor/Modify Tx

    oxaprozin + coagulation factor IX

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • Coxanto (oxaprozin)
    +
    coagulation factor VIIa
    1 interaction

    Monitor/Modify Tx

    oxaprozin + coagulation factor VIIa

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • Coxanto (oxaprozin)
    +
    coagulation factor XIII A-subunit
    1 interaction

    Monitor/Modify Tx

    oxaprozin + coagulation factor XIII A-subunit

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • cocaine
  • Coxanto (oxaprozin)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cocaine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • colistimethate
  • Coxanto (oxaprozin)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + colistimethate

    monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • collagenase clostridium histolyticum
  • Coxanto (oxaprozin)
    +
    collagenase clostridium histolyticum
    1 interaction

    Monitor/Modify Tx

    oxaprozin + collagenase clostridium histolyticum

    monitor injection site bleeding s/sx: combo may incr. risk of localized bleeding, including severe (additive effects)

  • concizumab
  • Coxanto (oxaprozin)
    +
    concizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + concizumab

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • copanlisib
  • Coxanto (oxaprozin)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • copper histidinate
  • Coxanto (oxaprozin)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + copper histidinate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • corticotropin
  • Coxanto (oxaprozin)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + corticotropin

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • cortisone
  • Coxanto (oxaprozin)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cortisone

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • creatine
  • Coxanto (oxaprozin)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + creatine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • cyclophosphamide
  • Coxanto (oxaprozin)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cyclophosphamide

    monitor CBC, renal, cardiac fxn: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • cyclosporine
  • Coxanto (oxaprozin)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cyclosporine

    monitor renal fxn, potassium, BP: combo may incr. risk of nephrotoxicity, hyperkalemia, HTN (additive effects)

  • cysteamine
  • Coxanto (oxaprozin)
    +
    cysteamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cysteamine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • cytomegalovirus immune globulin
  • Coxanto (oxaprozin)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + cytomegalovirus immune globulin

    monitor renal fxn, thrombosis s/sx; use lowest cytomegalovirus immune globulin concentration and infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • dabigatran
  • Coxanto (oxaprozin)
    +
    dabigatran
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dabigatran

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • dalteparin
  • Coxanto (oxaprozin)
    +
    dalteparin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dalteparin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • danazol
  • Coxanto (oxaprozin)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + danazol

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • danshen
  • Coxanto (oxaprozin)
    +
    danshen
    1 interaction

    Monitor/Modify Tx

    oxaprozin + danshen

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • darbepoetin alfa
  • Coxanto (oxaprozin)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    oxaprozin + darbepoetin alfa

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • dasatinib
  • Coxanto (oxaprozin)
    +
    dasatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dasatinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • decitabine
  • Coxanto (oxaprozin)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + decitabine

    monitor potassium w/ IV decitabine use: combo may incr. risk of hyperkalemia (additive effects)

  • deferasirox
  • Coxanto (oxaprozin)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    oxaprozin + deferasirox

    monitor CBC, renal fxn, bleeding s/sx, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, GI ulceration, perforation, bleeding (including life-threatening), auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Coxanto (oxaprozin)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + deferoxamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • defibrotide
  • Coxanto (oxaprozin)
    +
    defibrotide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + defibrotide

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • deflazacort
  • Coxanto (oxaprozin)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    oxaprozin + deflazacort

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • desmopressin
  • Coxanto (oxaprozin)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + desmopressin

    monitor BP, sodium: combo may incr. risk of HTN, hyponatremia, including life-threatening (additive effects)

  • desogestrel (contraceptive)
  • Coxanto (oxaprozin)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + desogestrel (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • desvenlafaxine
  • Coxanto (oxaprozin)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + desvenlafaxine

    monitor bleeding s/sx, BP: combo may incr. risk of GI or other bleeding (including life-threatening), HTN (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • deuruxolitinib
  • Coxanto (oxaprozin)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + deuruxolitinib

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • dexamethasone
  • Coxanto (oxaprozin)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dexamethasone

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • dexmethylphenidate
  • Coxanto (oxaprozin)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Coxanto (oxaprozin)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac ophthalmic
  • Coxanto (oxaprozin)
    +
    diclofenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + diclofenac ophthalmic

    monitor bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • dienogest (contraceptive)
  • Coxanto (oxaprozin)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dienogest (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • diethylpropion
  • Coxanto (oxaprozin)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    oxaprozin + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • digoxin
  • Coxanto (oxaprozin)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + digoxin

    monitor digoxin levels, HR: combo may incr. digoxin levels, risk of bradycardia, AV block, other adverse effects (mechanism unknown)

  • dihydroergotamine
  • Coxanto (oxaprozin)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Coxanto (oxaprozin)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    oxaprozin + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dimethyl fumarate
  • Coxanto (oxaprozin)
    +
    dimethyl fumarate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dimethyl fumarate

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • diosmin
  • Coxanto (oxaprozin)
    +
    diosmin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + diosmin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • dipyridamole
  • Coxanto (oxaprozin)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dipyridamole

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • diroximel fumarate
  • Coxanto (oxaprozin)
    +
    diroximel fumarate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + diroximel fumarate

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • dobutamine
  • Coxanto (oxaprozin)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • donepezil
  • Coxanto (oxaprozin)
    +
    donepezil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + donepezil

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • dopamine
  • Coxanto (oxaprozin)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Coxanto (oxaprozin)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    oxaprozin + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Coxanto (oxaprozin)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Coxanto (oxaprozin)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • drospirenone (contraceptive)
  • Coxanto (oxaprozin)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + drospirenone (contraceptive)

    monitor potassium, thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of hyperkalemia, thromboembolism (additive effects)

  • drospirenone (hormone replacement)
  • Coxanto (oxaprozin)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + drospirenone (hormone replacement)

    monitor potassium, thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of hyperkalemia, thromboembolism (additive effects)

  • droxidopa
  • Coxanto (oxaprozin)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    oxaprozin + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • duloxetine
  • Coxanto (oxaprozin)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + duloxetine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • edoxaban
  • Coxanto (oxaprozin)
    +
    edoxaban
    1 interaction

    Monitor/Modify Tx

    oxaprozin + edoxaban

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • eletriptan
  • Coxanto (oxaprozin)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eltrombopag
  • Coxanto (oxaprozin)
    +
    eltrombopag
    1 interaction

    Monitor/Modify Tx

    oxaprozin + eltrombopag

    monitor platelets, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • enalapril
  • Coxanto (oxaprozin)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + enalapril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • enalaprilat
  • Coxanto (oxaprozin)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    oxaprozin + enalaprilat

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • encorafenib
  • Coxanto (oxaprozin)
    +
    encorafenib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + encorafenib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • ephedra
  • Coxanto (oxaprozin)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Coxanto (oxaprozin)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Coxanto (oxaprozin)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Coxanto (oxaprozin)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + epinephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epirubicin
  • Coxanto (oxaprozin)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + epirubicin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • eplerenone
  • Coxanto (oxaprozin)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + eplerenone

    monitor potassium, BP: combo may incr. risk of hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • epoetin alfa
  • Coxanto (oxaprozin)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    oxaprozin + epoetin alfa

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • epoprostenol
  • Coxanto (oxaprozin)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + epoprostenol

    monitor bleeding s/sx: combo may incr. risk of bleeding, including life-threatening (additive effects)

  • eptifibatide
  • Coxanto (oxaprozin)
    +
    eptifibatide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + eptifibatide

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • eptinezumab
  • Coxanto (oxaprozin)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Coxanto (oxaprozin)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Coxanto (oxaprozin)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • erlotinib
  • Coxanto (oxaprozin)
    +
    erlotinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + erlotinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • escitalopram
  • Coxanto (oxaprozin)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    oxaprozin + escitalopram

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • esketamine
  • Coxanto (oxaprozin)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Coxanto (oxaprozin)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Coxanto (oxaprozin)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + estetrol (contraceptive)

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • estradiol (contraceptive)
  • Coxanto (oxaprozin)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + estradiol (contraceptive)

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • estradiol (hormone replacement)
  • Coxanto (oxaprozin)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + estradiol (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, conjugated (hormone replacement)
  • Coxanto (oxaprozin)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + estrogens, conjugated (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, esterified (hormone replacement)
  • Coxanto (oxaprozin)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + estrogens, esterified (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • etelcalcetide
  • Coxanto (oxaprozin)
    +
    etelcalcetide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + etelcalcetide

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • ethacrynic acid
  • Coxanto (oxaprozin)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ethacrynic acid

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. ethacrynic acid efficacy (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • Coxanto (oxaprozin)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ethanol (alcoholic beverage)

    monitor bleeding signs/symptoms, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Coxanto (oxaprozin)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ethinyl estradiol (contraceptive)

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • ethinyl estradiol (hormone replacement)
  • Coxanto (oxaprozin)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ethinyl estradiol (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ethynodiol (contraceptive)
  • Coxanto (oxaprozin)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ethynodiol (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • etonogestrel (contraceptive)
  • Coxanto (oxaprozin)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + etonogestrel (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • etrasimod
  • Coxanto (oxaprozin)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    oxaprozin + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • evening primrose oil
  • Coxanto (oxaprozin)
    +
    evening primrose oil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + evening primrose oil

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • everolimus
  • Coxanto (oxaprozin)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    oxaprozin + everolimus

    monitor thrombosis s/sx, especially if immunosuppressant use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • factor XIII concentrate
  • Coxanto (oxaprozin)
    +
    factor XIII concentrate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + factor XIII concentrate

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • Coxanto (oxaprozin)
    +
    faricimab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + faricimab

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • Coxanto (oxaprozin)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fedratinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • felodipine
  • Coxanto (oxaprozin)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Coxanto (oxaprozin)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenofibrate
  • Coxanto (oxaprozin)
    +
    fenofibrate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fenofibrate

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • Coxanto (oxaprozin)
    +
    fenofibric acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fenofibric acid

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • fenoldopam
  • Coxanto (oxaprozin)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenugreek
  • Coxanto (oxaprozin)
    +
    fenugreek
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fenugreek

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • fibrinogen (human)
  • Coxanto (oxaprozin)
    +
    fibrinogen (human)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fibrinogen (human)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • finerenone
  • Coxanto (oxaprozin)
    +
    finerenone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + finerenone

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • fingolimod
  • Coxanto (oxaprozin)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fitusiran
  • Coxanto (oxaprozin)
    +
    fitusiran
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fitusiran

    monitor antithrombin activity level, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • flucytosine
  • Coxanto (oxaprozin)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + flucytosine

    monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludrocortisone
  • Coxanto (oxaprozin)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fludrocortisone

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • fluoxetine
  • Coxanto (oxaprozin)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fluoxetine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • flurbiprofen ophthalmic
  • Coxanto (oxaprozin)
    +
    flurbiprofen ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + flurbiprofen ophthalmic

    monitor bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • fluvoxamine
  • Coxanto (oxaprozin)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fluvoxamine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • follitropin
  • Coxanto (oxaprozin)
    +
    follitropin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + follitropin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • formoterol inhaled
  • Coxanto (oxaprozin)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + formoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • foscarnet
  • Coxanto (oxaprozin)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    oxaprozin + foscarnet

    monitor CBC, renal fxn: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fosinopril
  • Coxanto (oxaprozin)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fosinopril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • fostamatinib
  • Coxanto (oxaprozin)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Coxanto (oxaprozin)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Coxanto (oxaprozin)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Coxanto (oxaprozin)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + fruquintinib

    monitor BP, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN (including hypertensive crisis), thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • furosemide
  • Coxanto (oxaprozin)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + furosemide

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • galantamine
  • Coxanto (oxaprozin)
    +
    galantamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + galantamine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • galcanezumab
  • Coxanto (oxaprozin)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ganciclovir
  • Coxanto (oxaprozin)
    +
    ganciclovir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • garlic
  • Coxanto (oxaprozin)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + garlic

    monitor bleeding s/sx, especially w/ supplemental garlic; dietary intake OK: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • gefitinib
  • Coxanto (oxaprozin)
    +
    gefitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + gefitinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • gemtuzumab ozogamicin
  • Coxanto (oxaprozin)
    +
    gemtuzumab ozogamicin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + gemtuzumab ozogamicin

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • gentamicin
  • Coxanto (oxaprozin)
    +
    gentamicin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + gentamicin

    monitor gentamicin levels, renal fxn, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • ginkgo
  • Coxanto (oxaprozin)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ginkgo

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • guanfacine
  • Coxanto (oxaprozin)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • heparin
  • Coxanto (oxaprozin)
    +
    heparin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + heparin

    monitor bleeding s/sx, potassium: combo may incr. risk of GI or other bleeding (including life-threatening), hyperkalemia (additive effects)

  • hepatitis B immune globulin
  • Coxanto (oxaprozin)
    +
    hepatitis B immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hepatitis B immune globulin

    monitor thrombosis s/sx; use lowest hepatitis B immune globulin infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • hoodia
  • Coxanto (oxaprozin)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydralazine
  • Coxanto (oxaprozin)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Coxanto (oxaprozin)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hydrochlorothiazide

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • hydrocortisone
  • Coxanto (oxaprozin)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hydrocortisone

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • hydroxocobalamin IV
  • Coxanto (oxaprozin)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    oxaprozin + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibandronate
  • Coxanto (oxaprozin)
    +
    ibandronate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ibandronate

    monitor bleeding s/sx if oral ibandronate use: combo may incr. risk of upper GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • ibrutinib
  • Coxanto (oxaprozin)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ibrutinib

    monitor bleeding s/sx, BP: combo may incr. risk of GI or other bleeding (including life-threatening), HTN (additive effects)

  • icosapent ethyl
  • Coxanto (oxaprozin)
    +
    icosapent ethyl
    1 interaction

    Monitor/Modify Tx

    oxaprozin + icosapent ethyl

    monitor bleeding s/sx: combo may incr. risk of bleeding, including life-threatening (additive effects)

  • ifosfamide
  • Coxanto (oxaprozin)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ifosfamide

    monitor CBC, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • imatinib
  • Coxanto (oxaprozin)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + imatinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • immune globulin
  • Coxanto (oxaprozin)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + immune globulin

    monitor renal fxn, thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • indapamide
  • Coxanto (oxaprozin)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + indapamide

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. indapamide efficacy (additive effects; antagonistic effects)

  • iodixanol
  • Coxanto (oxaprozin)
    +
    iodixanol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iodixanol

    monitor renal function, thrombosis signs/symptoms; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iohexol
  • Coxanto (oxaprozin)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iohexol

    monitor renal fxn, thrombosis s/sx if IV iohexol use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iomeprol
  • Coxanto (oxaprozin)
    +
    iomeprol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iomeprol

    monitor renal fxn, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iopamidol
  • Coxanto (oxaprozin)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iopamidol

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iopromide
  • Coxanto (oxaprozin)
    +
    iopromide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iopromide

    monitor renal function, thrombosis signs/symptoms; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iothalamate meglumine
  • Coxanto (oxaprozin)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function, thrombosis signs/symptoms; use lowest effective oxaprozin dose, shortest effective tx duration; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ioversol
  • Coxanto (oxaprozin)
    +
    ioversol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ioversol

    monitor renal function, thrombosis signs/symptoms; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • irbesartan
  • Coxanto (oxaprozin)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + irbesartan

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • isradipine
  • Coxanto (oxaprozin)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Coxanto (oxaprozin)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac ophthalmic
  • Coxanto (oxaprozin)
    +
    ketorolac ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ketorolac ophthalmic

    monitor bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • labetalol
  • Coxanto (oxaprozin)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • landiolol
  • Coxanto (oxaprozin)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + landiolol

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • lanreotide
  • Coxanto (oxaprozin)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lanthanum
  • Coxanto (oxaprozin)
    +
    lanthanum
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lanthanum

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • lazertinib
  • Coxanto (oxaprozin)
    +
    lazertinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lazertinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • leflunomide
  • Coxanto (oxaprozin)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenalidomide
  • Coxanto (oxaprozin)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lenalidomide

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • lenvatinib
  • Coxanto (oxaprozin)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lenvatinib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • levalbuterol inhaled
  • Coxanto (oxaprozin)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + levalbuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levomilnacipran
  • Coxanto (oxaprozin)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    oxaprozin + levomilnacipran

    monitor bleeding s/sx, BP: combo may incr. risk of GI or other bleeding (including life-threatening), HTN (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • levonorgestrel (contraceptive)
  • Coxanto (oxaprozin)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + levonorgestrel (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (hormone replacement)
  • Coxanto (oxaprozin)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + levonorgestrel (hormone replacement)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • licorice
  • Coxanto (oxaprozin)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    oxaprozin + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lifileucel
  • Coxanto (oxaprozin)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lifileucel

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • lisdexamfetamine
  • Coxanto (oxaprozin)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lithium
  • Coxanto (oxaprozin)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lithium

    monitor lithium levels, renal fxn: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lomustine
  • Coxanto (oxaprozin)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lomustine

    monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lorlatinib
  • Coxanto (oxaprozin)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Coxanto (oxaprozin)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + losartan

    monitor BP, renal fxn, potassium: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • lumacaftor/ivacaftor
  • Coxanto (oxaprozin)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Coxanto (oxaprozin)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    oxaprozin + luspatercept

    monitor BP; if beta thalassemia use, monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • lusutrombopag
  • Coxanto (oxaprozin)
    +
    lusutrombopag
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lusutrombopag

    monitor platelets, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • lutetium Lu 177 dotatate
  • Coxanto (oxaprozin)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lutetium Lu 177 dotatate

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Coxanto (oxaprozin)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + lutetium Lu 177 vipivotide tetraxetan

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Coxanto (oxaprozin)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + magnesium citrate

    monitor renal fxn, especially if magnesium citrate bowel prep use: combo may incr. risk of renal impairment (additive effects)

  • mannitol
  • Coxanto (oxaprozin)
    +
    mannitol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mannitol

    monitor renal fxn: combo may incr. mannitol levels, risk of renal impairment, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • medroxyprogesterone (contraceptive)
  • Coxanto (oxaprozin)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + medroxyprogesterone (contraceptive)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • Coxanto (oxaprozin)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + medroxyprogesterone (hormone replacement)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • megestrol
  • Coxanto (oxaprozin)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + megestrol

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • menotropins
  • Coxanto (oxaprozin)
    +
    menotropins
    1 interaction

    Monitor/Modify Tx

    oxaprozin + menotropins

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • mesalamine
  • Coxanto (oxaprozin)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mesalamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Coxanto (oxaprozin)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mesalamine rectal

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • methamphetamine
  • Coxanto (oxaprozin)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Coxanto (oxaprozin)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methoxy polyethylene glycol-epoetin beta

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • methyl salicylate topical
  • Coxanto (oxaprozin)
    +
    methyl salicylate topical
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methyl salicylate topical

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, systemic salicylate absorption may occur from topical use)

  • methyldopa
  • Coxanto (oxaprozin)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Coxanto (oxaprozin)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • Coxanto (oxaprozin)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methylprednisolone
  • Coxanto (oxaprozin)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methylprednisolone

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • methyltestosterone
  • Coxanto (oxaprozin)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + methyltestosterone

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • metoclopramide
  • Coxanto (oxaprozin)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Coxanto (oxaprozin)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + metolazone

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. metolazone efficacy (additive effects; antagonistic effects)

  • metoprolol
  • Coxanto (oxaprozin)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milnacipran
  • Coxanto (oxaprozin)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    oxaprozin + milnacipran

    monitor bleeding s/sx, BP: combo may incr. risk of HTN, GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • minoxidil
  • Coxanto (oxaprozin)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Coxanto (oxaprozin)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mitomycin
  • Coxanto (oxaprozin)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mitomycin

    monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • mitotane
  • Coxanto (oxaprozin)
    +
    mitotane
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mitotane

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • modafinil
  • Coxanto (oxaprozin)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + modafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • moexipril
  • Coxanto (oxaprozin)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + moexipril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • momelotinib
  • Coxanto (oxaprozin)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + momelotinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • monomethyl fumarate
  • Coxanto (oxaprozin)
    +
    monomethyl fumarate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + monomethyl fumarate

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • mycophenolate mofetil
  • Coxanto (oxaprozin)
    +
    mycophenolate mofetil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mycophenolate mofetil

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • mycophenolic acid
  • Coxanto (oxaprozin)
    +
    mycophenolic acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + mycophenolic acid

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • nadolol
  • Coxanto (oxaprozin)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naratriptan
  • Coxanto (oxaprozin)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nattokinase
  • Coxanto (oxaprozin)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nattokinase

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • naxitamab
  • Coxanto (oxaprozin)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Coxanto (oxaprozin)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • necitumumab
  • Coxanto (oxaprozin)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + necitumumab

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • neomycin
  • Coxanto (oxaprozin)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • nepafenac ophthalmic
  • Coxanto (oxaprozin)
    +
    nepafenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nepafenac ophthalmic

    monitor bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • niacin (vitamin B3)
  • Coxanto (oxaprozin)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + niacin (vitamin B3)

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • nicardipine
  • Coxanto (oxaprozin)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicotine
  • Coxanto (oxaprozin)
    +
    nicotine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nicotine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nifedipine
  • Coxanto (oxaprozin)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Coxanto (oxaprozin)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nilotinib

    monitor potassium, bleeding s/sx: combo may incr. risk of hyperkalemia, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • nimodipine
  • Coxanto (oxaprozin)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • nintedanib
  • Coxanto (oxaprozin)
    +
    nintedanib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nintedanib

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • niraparib
  • Coxanto (oxaprozin)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Coxanto (oxaprozin)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norelgestromin (contraceptive)
  • Coxanto (oxaprozin)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norelgestromin (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • norepinephrine
  • Coxanto (oxaprozin)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • norethindrone (contraceptive)
  • Coxanto (oxaprozin)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norethindrone (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (hormone replacement)
  • Coxanto (oxaprozin)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norethindrone (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • norgestimate (contraceptive)
  • Coxanto (oxaprozin)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norgestimate (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • norgestrel (contraceptive)
  • Coxanto (oxaprozin)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + norgestrel (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • nusinersen
  • Coxanto (oxaprozin)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    oxaprozin + nusinersen

    monitor platelets, bleeding s/sx, renal fxn: combo may incr. risk of nephrotoxicity, GI or other bleeding, including life-threatening (additive effects)

  • obinutuzumab
  • Coxanto (oxaprozin)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + obinutuzumab

    monitor BP, platelets, bleeding or thrombosis s/sx; consider holding oxaprozin, especially during first obinutuzumab cycle: combo may incr. risk of HTN (including hypertensive crisis), thromboembolism, severe bleeding, including life-threatening (additive effects)

  • olaparib
  • Coxanto (oxaprozin)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + olaparib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • olmesartan medoxomil
  • Coxanto (oxaprozin)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + olmesartan medoxomil

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olodaterol inhaled
  • Coxanto (oxaprozin)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + olodaterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • olsalazine
  • Coxanto (oxaprozin)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + olsalazine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • omega-3-acid
  • Coxanto (oxaprozin)
    +
    omega-3-acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + omega-3-acid

    monitor bleeding s/sx: combo may incr. risk of bleeding, including life-threatening (additive effects)

  • osilodrostat
  • Coxanto (oxaprozin)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    oxaprozin + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ospemifene
  • Coxanto (oxaprozin)
    +
    ospemifene
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ospemifene

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • oxaliplatin
  • Coxanto (oxaprozin)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + oxaliplatin

    monitor ECG, CBC, renal fxn, bleeding s/sx, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, GI or other bleeding (including life-threatening), auditory, vestibular, other adverse effects (additive effects)

  • oxymetazoline nasal
  • Coxanto (oxaprozin)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    oxaprozin + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Coxanto (oxaprozin)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Coxanto (oxaprozin)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • pacritinib
  • Coxanto (oxaprozin)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pacritinib

    monitor platelets, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism (additive effects)

  • pamidronate
  • Coxanto (oxaprozin)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pamidronate

    monitor renal fxn: combo may incr. pamidronate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • paromomycin
  • Coxanto (oxaprozin)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • paroxetine
  • Coxanto (oxaprozin)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + paroxetine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • pazopanib
  • Coxanto (oxaprozin)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pazopanib

    monitor BP, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • pegaspargase
  • Coxanto (oxaprozin)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pegaspargase

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including life-threatening), thromboembolism (additive effects)

  • penicillamine
  • Coxanto (oxaprozin)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + penicillamine

    monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillin G
  • Coxanto (oxaprozin)
    +
    penicillin G
    1 interaction

    Monitor/Modify Tx

    oxaprozin + penicillin G

    monitor bleeding s/sx, especially w/ large penicillin G doses and/or concomitant renal impairment: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • pentamidine
  • Coxanto (oxaprozin)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pentamidine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • pentosan polysulfate sodium
  • Coxanto (oxaprozin)
    +
    pentosan polysulfate sodium
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pentosan polysulfate sodium

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • pentostatin
  • Coxanto (oxaprozin)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pentostatin

    monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentoxifylline
  • Coxanto (oxaprozin)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pentoxifylline

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • perindopril
  • Coxanto (oxaprozin)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + perindopril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • pexidartinib
  • Coxanto (oxaprozin)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Coxanto (oxaprozin)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Coxanto (oxaprozin)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Coxanto (oxaprozin)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Coxanto (oxaprozin)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Coxanto (oxaprozin)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Coxanto (oxaprozin)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Coxanto (oxaprozin)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Coxanto (oxaprozin)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Coxanto (oxaprozin)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    oxaprozin + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Coxanto (oxaprozin)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piperacillin
  • Coxanto (oxaprozin)
    +
    piperacillin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + piperacillin

    monitor bleeding s/sx, especially w/ prolonged piperacillin tx and/or concomitant renal impairment: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • pirtobrutinib
  • Coxanto (oxaprozin)
    +
    pirtobrutinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pirtobrutinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • plasminogen, human
  • Coxanto (oxaprozin)
    +
    plasminogen, human
    1 interaction

    Monitor/Modify Tx

    oxaprozin + plasminogen, human

    monitor bleeding s/sx, especially during and x4h after plasminogen infusion: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • plazomicin
  • Coxanto (oxaprozin)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + plazomicin

    monitor plazomicin levels, renal fxn, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polyethylene glycol
  • Coxanto (oxaprozin)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + polyethylene glycol

    monitor renal fxn, especially if polyethylene glycol bowel prep use: combo may incr. risk of renal impairment (additive effects)

  • polyethylene glycol/electrolytes
  • Coxanto (oxaprozin)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    oxaprozin + polyethylene glycol/ electrolytes

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • polymyxin B
  • Coxanto (oxaprozin)
    +
    polymyxin B
    1 interaction

    Monitor/Modify Tx

    oxaprozin + polymyxin B

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • pomalidomide
  • Coxanto (oxaprozin)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pomalidomide

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ponatinib
  • Coxanto (oxaprozin)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ponatinib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • ponesimod
  • Coxanto (oxaprozin)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • potassium acid phosphate
  • Coxanto (oxaprozin)
    +
    potassium acid phosphate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + potassium acid phosphate

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • potassium bicarbonate
  • Coxanto (oxaprozin)
    +
    potassium bicarbonate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + potassium bicarbonate

    monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium citrate
  • Coxanto (oxaprozin)
    +
    potassium citrate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + potassium citrate

    monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium iodide
  • Coxanto (oxaprozin)
    +
    potassium iodide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + potassium iodide

    monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • pralsetinib
  • Coxanto (oxaprozin)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pralsetinib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI or other bleeding, including life-threatening (additive effects)

  • prasugrel
  • Coxanto (oxaprozin)
    +
    prasugrel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + prasugrel

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • prazosin
  • Coxanto (oxaprozin)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Coxanto (oxaprozin)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + prednisolone

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • prednisone
  • Coxanto (oxaprozin)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + prednisone

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • progesterone (hormone replacement)
  • Coxanto (oxaprozin)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + progesterone (hormone replacement)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • Coxanto (oxaprozin)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + progesterone vaginal (hormone replacement)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • propranolol
  • Coxanto (oxaprozin)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prothrombin complex concentrate (human)
  • Coxanto (oxaprozin)
    +
    prothrombin complex concentrate (human)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + prothrombin complex concentrate (human)

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • pseudoephedrine
  • Coxanto (oxaprozin)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pyridostigmine
  • Coxanto (oxaprozin)
    +
    pyridostigmine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + pyridostigmine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • quetiapine
  • Coxanto (oxaprozin)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Coxanto (oxaprozin)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + quinapril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • raloxifene
  • Coxanto (oxaprozin)
    +
    raloxifene
    1 interaction

    Monitor/Modify Tx

    oxaprozin + raloxifene

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ramipril
  • Coxanto (oxaprozin)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ramipril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • ramucirumab
  • Coxanto (oxaprozin)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ramucirumab

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • ranibizumab
  • Coxanto (oxaprozin)
    +
    ranibizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ranibizumab

    monitor bleeding or thrombosis s/sx; thrombosis risk may be lower if ocular implant use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of ocular hemorrhage, thromboembolism (additive effects)

  • regorafenib
  • Coxanto (oxaprozin)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + regorafenib

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • remibrutinib
  • Coxanto (oxaprozin)
    +
    remibrutinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + remibrutinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • resveratrol
  • Coxanto (oxaprozin)
    +
    resveratrol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + resveratrol

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • reteplase
  • Coxanto (oxaprozin)
    +
    reteplase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + reteplase

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • revakinagene taroretcel
  • Coxanto (oxaprozin)
    +
    revakinagene taroretcel
    1 interaction

    Monitor/Modify Tx

    oxaprozin + revakinagene taroretcel

    monitor bleeding s/sx; hold oxaprozin prior to implant insertion: combo may incr. risk of ocular hemorrhage (additive effects)

  • Rho(D) immune globulin
  • Coxanto (oxaprozin)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + Rho(D) immune globulin

    monitor renal fxn, thrombosis s/sx; use lowest Rho(D) immune globulin infusion rate possible; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • rimegepant
  • Coxanto (oxaprozin)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Coxanto (oxaprozin)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • risedronate
  • Coxanto (oxaprozin)
    +
    risedronate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + risedronate

    monitor bleeding s/sx: combo may incr. risk of upper GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • ritlecitinib
  • Coxanto (oxaprozin)
    +
    ritlecitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ritlecitinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • rituximab
  • Coxanto (oxaprozin)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rituximab

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rivaroxaban
  • Coxanto (oxaprozin)
    +
    rivaroxaban
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rivaroxaban

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • rivastigmine
  • Coxanto (oxaprozin)
    +
    rivastigmine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rivastigmine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • rizatriptan
  • Coxanto (oxaprozin)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • romiplostim
  • Coxanto (oxaprozin)
    +
    romiplostim
    1 interaction

    Monitor/Modify Tx

    oxaprozin + romiplostim

    monitor platelets, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ropeginterferon alfa-2b
  • Coxanto (oxaprozin)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ropeginterferon alfa-2b

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ropinirole
  • Coxanto (oxaprozin)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Coxanto (oxaprozin)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    oxaprozin + rotigotine transdermal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ruxolitinib
  • Coxanto (oxaprozin)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ruxolitinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib topical
  • Coxanto (oxaprozin)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ruxolitinib topical

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • salmeterol inhaled
  • Coxanto (oxaprozin)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + salmeterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • saw palmetto
  • Coxanto (oxaprozin)
    +
    saw palmetto
    1 interaction

    Monitor/Modify Tx

    oxaprozin + saw palmetto

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • segesterone (contraceptive)
  • Coxanto (oxaprozin)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    oxaprozin + segesterone (contraceptive)

    monitor thrombosis s/sx, especially w/ concomitant estrogen use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • selpercatinib
  • Coxanto (oxaprozin)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + selpercatinib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI or other bleeding, including life-threatening (additive effects)

  • selumetinib
  • Coxanto (oxaprozin)
    +
    selumetinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + selumetinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet and anticoagulant effects augmented by vitamin E content in selumetinib capsules)

  • sepiapterin
  • Coxanto (oxaprozin)
    +
    sepiapterin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sepiapterin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • sertraline
  • Coxanto (oxaprozin)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sertraline

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • sincalide
  • Coxanto (oxaprozin)
    +
    sincalide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sincalide

    if sincalide gallbladder contraction stimulation use, consider D/C oxaprozin prior to sincalide admin.: combo may alter sincalide efficacy, interfere with test results (gallbladder motility/contractility altered)

  • siponimod
  • Coxanto (oxaprozin)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    oxaprozin + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sipuleucel-T
  • Coxanto (oxaprozin)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sipuleucel-T

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • sirolimus
  • Coxanto (oxaprozin)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sirolimus albumin-bound
  • Coxanto (oxaprozin)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sirolimus albumin-bound

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • sitagliptin
  • Coxanto (oxaprozin)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sitagliptin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium picosulfate
  • Coxanto (oxaprozin)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sodium picosulfate

    monitor renal function: combo may incr. risk of renal impairment (additive effects)

  • sodium tetradecyl sulfate
  • Coxanto (oxaprozin)
    +
    sodium tetradecyl sulfate
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sodium tetradecyl sulfate

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • solriamfetol
  • Coxanto (oxaprozin)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + solriamfetol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sorafenib
  • Coxanto (oxaprozin)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sorafenib

    monitor bleeding s/sx, BP: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN (additive effects)

  • sotatercept
  • Coxanto (oxaprozin)
    +
    sotatercept
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sotatercept

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • sparsentan
  • Coxanto (oxaprozin)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sparsentan

    monitor renal fxn, potassium: combo may incr. risk of nephrotoxicity, hyperkalemia (additive effects)

  • spironolactone
  • Coxanto (oxaprozin)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + spironolactone

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, severe hyperkalemia; may decr. spironolactone efficacy (additive effects; antagonistic effects)

  • streptomycin
  • Coxanto (oxaprozin)
    +
    streptomycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + streptomycin

    monitor renal fxn, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Coxanto (oxaprozin)
    +
    streptozocin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + streptozocin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • succinylcholine
  • Coxanto (oxaprozin)
    +
    succinylcholine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + succinylcholine

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • sulfate bowel prep
  • Coxanto (oxaprozin)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sulfate bowel prep

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • sumatriptan
  • Coxanto (oxaprozin)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Coxanto (oxaprozin)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + sunitinib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • tagraxofusp
  • Coxanto (oxaprozin)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tamoxifen
  • Coxanto (oxaprozin)
    +
    tamoxifen
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tamoxifen

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • telavancin
  • Coxanto (oxaprozin)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + telavancin

    monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Coxanto (oxaprozin)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + telmisartan

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • temsirolimus
  • Coxanto (oxaprozin)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    oxaprozin + temsirolimus

    monitor renal fxn, bleeding s/sx: combo may incr. risk of nephrotoxicity, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • tenecteplase
  • Coxanto (oxaprozin)
    +
    tenecteplase
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tenecteplase

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • tenofovir alafenamide
  • Coxanto (oxaprozin)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tenofovir alafenamide

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • terazosin
  • Coxanto (oxaprozin)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Coxanto (oxaprozin)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    oxaprozin + terbutaline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • teriflunomide
  • Coxanto (oxaprozin)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Coxanto (oxaprozin)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + testosterone

    monitor BP, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism (additive effects)

  • thalidomide
  • Coxanto (oxaprozin)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + thalidomide

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ticagrelor
  • Coxanto (oxaprozin)
    +
    ticagrelor
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ticagrelor

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • timolol
  • Coxanto (oxaprozin)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    oxaprozin + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tiopronin
  • Coxanto (oxaprozin)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tiopronin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tipranavir
  • Coxanto (oxaprozin)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tipranavir

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • tirofiban
  • Coxanto (oxaprozin)
    +
    tirofiban
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tirofiban

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • tisotumab vedotin
  • Coxanto (oxaprozin)
    +
    tisotumab vedotin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tisotumab vedotin

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • tivozanib
  • Coxanto (oxaprozin)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tivozanib

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk HTN (including hypertensive crisis), GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • tobramycin
  • Coxanto (oxaprozin)
    +
    tobramycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tobramycin

    monitor tobramycin levels, renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Coxanto (oxaprozin)
    +
    tobramycin inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tobramycin inhaled

    monitor renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tocilizumab
  • Coxanto (oxaprozin)
    +
    tocilizumab
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tocilizumab

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • tofacitinib
  • Coxanto (oxaprozin)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tofacitinib

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • tolvaptan
  • Coxanto (oxaprozin)
    +
    tolvaptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tolvaptan

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • toremifene
  • Coxanto (oxaprozin)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    oxaprozin + toremifene

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • torsemide
  • Coxanto (oxaprozin)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + torsemide

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. torsemide efficacy (additive effects; antagonistic effects)

  • tovorafenib
  • Coxanto (oxaprozin)
    +
    tovorafenib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tovorafenib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • trametinib
  • Coxanto (oxaprozin)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + trametinib

    monitor BP, bleeding or thrombosis s/sx, especially w/ concomitant dabrafenib use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • trandolapril
  • Coxanto (oxaprozin)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    oxaprozin + trandolapril

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • trazodone
  • Coxanto (oxaprozin)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + trazodone

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • treprostinil
  • Coxanto (oxaprozin)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + treprostinil

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • tretinoin
  • Coxanto (oxaprozin)
    +
    tretinoin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + tretinoin

    monitor thrombosis s/sx, especially during 1st month of tretinoin use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • triamcinolone
  • Coxanto (oxaprozin)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + triamcinolone

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • triamterene
  • Coxanto (oxaprozin)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    oxaprozin + triamterene

    monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, severe hyperkalemia; may decr. triamterene efficacy (additive effects; antagonistic effects)

  • trimethoprim
  • Coxanto (oxaprozin)
    +
    trimethoprim
    1 interaction

    Monitor/Modify Tx

    oxaprozin + trimethoprim

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • ubrogepant
  • Coxanto (oxaprozin)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • upadacitinib
  • Coxanto (oxaprozin)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + upadacitinib

    monitor bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • vadadustat
  • Coxanto (oxaprozin)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vadadustat

    monitor BP, Hgb, thrombosis or bleeding s/sx; use lowest effective vadadustat dose; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN (including hypertensive crisis), thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • valacyclovir
  • Coxanto (oxaprozin)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + valacyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valganciclovir
  • Coxanto (oxaprozin)
    +
    valganciclovir
    1 interaction

    Monitor/Modify Tx

    oxaprozin + valganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • valoctocogene roxaparvovec
  • Coxanto (oxaprozin)
    +
    valoctocogene roxaparvovec
    1 interaction

    Monitor/Modify Tx

    oxaprozin + valoctocogene roxaparvovec

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • valproic acid
  • Coxanto (oxaprozin)
    +
    valproic acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + valproic acid

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • vamorolone
  • Coxanto (oxaprozin)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vamorolone

    monitor BP, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • vancomycin
  • Coxanto (oxaprozin)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • vandetanib
  • Coxanto (oxaprozin)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vandetanib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI or other bleeding, including life-threatening (additive effects)

  • varicella zoster immune globulin
  • Coxanto (oxaprozin)
    +
    varicella zoster immune globulin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + varicella zoster immune globulin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • vasopressin
  • Coxanto (oxaprozin)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vasopressin

    monitor BP, sodium: combo may incr. risk of HTN, hyponatremia (additive effects)

  • venlafaxine
  • Coxanto (oxaprozin)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + venlafaxine

    monitor bleeding s/sx, BP: combo may incr. risk of GI or other bleeding (including life-threatening), HTN (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • verapamil
  • Coxanto (oxaprozin)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    oxaprozin + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Coxanto (oxaprozin)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vilanterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vilazodone
  • Coxanto (oxaprozin)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vilazodone

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • viloxazine
  • Coxanto (oxaprozin)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + viloxazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vinpocetine
  • Coxanto (oxaprozin)
    +
    vinpocetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vinpocetine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • voclosporin
  • Coxanto (oxaprozin)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + voclosporin

    monitor potassium, renal fxn, BP: combo may incr. risk of severe hyperkalemia, nephrotoxicity, HTN (additive effects)

  • von Willebrand factor
  • Coxanto (oxaprozin)
    +
    von Willebrand factor
    1 interaction

    Monitor/Modify Tx

    oxaprozin + von Willebrand factor

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • vorapaxar
  • Coxanto (oxaprozin)
    +
    vorapaxar
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vorapaxar

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • vorinostat
  • Coxanto (oxaprozin)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vorinostat

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • vortioxetine
  • Coxanto (oxaprozin)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    oxaprozin + vortioxetine

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • warfarin
  • Coxanto (oxaprozin)
    +
    warfarin
    1 interaction

    Monitor/Modify Tx

    oxaprozin + warfarin

    monitor INR, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (synergistic effects)

  • yohimbe
  • Coxanto (oxaprozin)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    oxaprozin + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zanubrutinib
  • Coxanto (oxaprozin)
    +
    zanubrutinib
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zanubrutinib

    monitor bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • zavegepant
  • Coxanto (oxaprozin)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Coxanto (oxaprozin)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    oxaprozin + ziv-aflibercept

    monitor bleeding or thrombosis s/sx, BP; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • zoledronic acid
  • Coxanto (oxaprozin)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zoledronic acid

    monitor renal fxn: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zolmitriptan
  • Coxanto (oxaprozin)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zonisamide
  • Coxanto (oxaprozin)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zonisamide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • zopapogene imadenovec
  • Coxanto (oxaprozin)
    +
    zopapogene imadenovec
    1 interaction

    Monitor/Modify Tx

    oxaprozin + zopapogene imadenovec

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

Caution Advised

  • acitretin
  • Coxanto (oxaprozin)
    +
    acitretin
    1 interaction

    Caution Advised

    oxaprozin + acitretin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • ciprofloxacin
  • Coxanto (oxaprozin)
    +
    ciprofloxacin
    1 interaction

    Caution Advised

    oxaprozin + ciprofloxacin

    caution advised: combo may incr. risk of CNS stimulation, seizures (mechanism unknown)

  • delafloxacin
  • Coxanto (oxaprozin)
    +
    delafloxacin
    1 interaction

    Caution Advised

    oxaprozin + delafloxacin

    caution advised: combo may incr. risk of CNS stimulation, seizures (mechanism unknown)

  • emtricitabine
  • Coxanto (oxaprozin)
    +
    emtricitabine
    1 interaction

    Caution Advised

    oxaprozin + emtricitabine

    caution advised, especially w/ high-dose oxaprozin: combo may incr. levels of both drugs, risk of adverse effects (renal secretion possibly inhibited)

  • levofloxacin
  • Coxanto (oxaprozin)
    +
    levofloxacin
    1 interaction

    Caution Advised

    oxaprozin + levofloxacin

    caution advised: combo may incr. risk of CNS stimulation, seizures (mechanism unknown)

  • methoxsalen
  • Coxanto (oxaprozin)
    +
    methoxsalen
    1 interaction

    Caution Advised

    oxaprozin + methoxsalen

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • moxifloxacin
  • Coxanto (oxaprozin)
    +
    moxifloxacin
    1 interaction

    Caution Advised

    oxaprozin + moxifloxacin

    caution advised: combo may incr. risk of CNS stimulation, seizures (mechanism unknown)

  • ofloxacin
  • Coxanto (oxaprozin)
    +
    ofloxacin
    1 interaction

    Caution Advised

    oxaprozin + ofloxacin

    caution advised: combo may incr. risk of CNS stimulation, seizures (mechanism unknown)

  • verteporfin
  • Coxanto (oxaprozin)
    +
    verteporfin
    1 interaction

    Caution Advised

    oxaprozin + verteporfin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@404a8002
  • GI bleeding
  • GI perforation
  • GI ulcer
  • MI
  • stroke
  • thromboembolism
  • HTN
  • CHF
  • CHF exacerbation
  • renal papillary necrosis
  • nephrotoxicity
  • hepatotoxicity
  • anaphylactoid reaction
  • bronchospasm
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • drug reaction with eosinophilia and systemic symptoms
  • generalized bullous fixed drug eruption
  • anemia
  • blood dyscrasia
  • prolonged bleeding time
  • hyperkalemia

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@5f88d919
  • dyspepsia
  • nausea
  • vomiting
  • abdominal pain
  • constipation
  • anorexia
  • flatulence
  • diarrhea
  • headache
  • dizziness
  • somnolence
  • sleep disturbance
  • pruritus
  • rash
  • ALT or AST elevated
  • edema
  • fluid retention
  • tinnitus
  • dysuria
  • renal impairment
  • anemia
  • prolonged bleeding time
  • photosensitivity
  • delayed ovulation

Safety/Monitoring .

Monitoring Parameters
Cr at baseline, then if renal or hepatic impairment, CHF, dehydration, or hypovolemia continue periodically; BP during tx start, then periodically; CBC, chemistry profile if long-term tx

Look/Sound-Alike Drug Names
oxaprozin confused with: OXcarbazepine; oxyBUTYnin

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit if <30 wk gestation, especially at 20-29 wk gestation, avoid use starting at 30 wk gestation; if must use at 20-29 wk gestation, limit dose and duration, and consider monitoring amniotic fluid if use >48h; risk of embryo-fetal toxicity and death low in 1st trimester based on conflicting human data; risk of fetal harm, including renal dysfunction and oligohydramnios, starting at 20 wk gestation and premature ductus arteriosus closure, starting at 30 wk gestation, based on human data with NSAID class and drug's mechanism of action

Individuals of Reproductive Potential

weigh risk/benefit in patients of childbearing potential trying to conceive, especially if long-term use; NSAIDs may reversibly delay ovulation during tx based on limited human or animal data and drug's mechanism of action

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding, consider short-acting NSAID; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@267c5538

Metabolism: for oxaprozin: liver; CYP450: unknown

Excretion: for oxaprozin: urine 65% (5% unchanged), feces 35%; Half-life: 41-55h

Subclass: Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Mechanism of Action
for oxaprozin: exact mechanism of action unknown; inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Solubiomix, LLC

com.epocrates.rxweb.beans.DrugOtherInfoBean@379f4ffb

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information